ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,077Medicare Part D Prescriptions Filled, Including Refills

Rank: 142 out of 625

$652K Total Retail Price of All Prescriptions

Rank: 114 out of 625

495 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 495 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 6,652 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LEVOTHYROXINE SODIUM 274 238 1 3
HYDROCODONE-ACETAMINOPHEN 231 165 S3 2 4
LISINOPRIL 224 182 3 5
FUROSEMIDE 217 155 4 7
SIMVASTATIN 203 159 5 2
AMLODIPINE BESYLATE 193 177 6 1
WARFARIN SODIUM 182 78 7 20
ZOLPIDEM TARTRATE 168 130 8 13
PRAVASTATIN SODIUM 156 145 9 8
METOPROLOL TARTRATE 145 131 10 11
ATORVASTATIN CALCIUM 144 119 11 9
OMEPRAZOLE 141 117 12 6
CRESTOR 124 89 13 17
METFORMIN HCL 122 108 14 10
HYDROCHLOROTHIAZIDE 121 108 15 12
OXYCODONE HCL-ACETAMINOPHEN 117 31 S2 16 87
GABAPENTIN 117 65 16 14
TRAZODONE HCL 114 69 18 51
NEXIUM 112 71 19 21
METOPROLOL SUCCINATE 112 96 19 15
PREDNISONE 108 90 21 37
LOSARTAN POTASSIUM 103 102 22 18
ATENOLOL 97 77 23 22
TRAMADOL HCL 95 49 24 16
CITALOPRAM HBR 92 76 25 24
KLOR-CON M20 89 46 26 47
LANSOPRAZOLE 72 54 27 159
AZITHROMYCIN 72 50 27 40
LEVETIRACETAM 71 37 29 98
DIGOXIN 70 57 30 55
PLAVIX 68 61 31 43
CLOPIDOGREL 67 59 32 30
TRIAMTERENE-HCTZ 65 62 33 53
GLYBURIDE-METFORMIN HCL 64 59 R 34 125
DONEPEZIL HCL 63 63 35 33
GEMFIBROZIL 62 62 36 127
FENTANYL 61 23 S2 37 110
ENDOCET 55 0 S2 38 124
AMITRIPTYLINE HCL 52 39 R 39 61
RANITIDINE HCL 50 33 40 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.